CD8A and hepatocellular carcinoma: Thus, we estimated the expression levels of the key molecules in two CD8+ T cells anti-tumor related pathways (IFN-gamma (82) and m6A pathway (83)) in low- and high-risk groups, and the results indicated that the majority of these molecules were expressed differently between two groups of HCC patients.